Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $687.85 | 8 | 77.6% |
| Food and Beverage | $198.87 | 2 | 22.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $279.89 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $184.55 | 2 | $0 (2024) |
| Aveo Pharmaceuticals, Inc. | $89.99 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $89.00 | 1 | $0 (2022) |
| Incyte Corporation | $84.99 | 1 | $0 (2023) |
| US WorldMeds, LLC | $84.31 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $73.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $235.25 | 3 | Aveo Pharmaceuticals, Inc. ($89.99) |
| 2023 | $363.60 | 4 | Lilly USA, LLC ($204.62) |
| 2022 | $203.56 | 2 | Alexion Pharmaceuticals, Inc. ($114.56) |
| 2018 | $84.31 | 1 | US WorldMeds, LLC ($84.31) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/15/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 02/16/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $75.27 | General |
| 01/02/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Education | In-kind items and services | $69.99 | General |
| Category: Rare Disease | ||||||
| 03/21/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $84.99 | General |
| 03/07/2023 | Lilly USA, LLC | — | Education | In-kind items and services | $107.52 | General |
| 01/28/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Education | In-kind items and services | $73.99 | General |
| Category: ONC | ||||||
| 01/18/2023 | Lilly USA, LLC | — | Education | In-kind items and services | $97.10 | General |
| 12/07/2022 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $89.00 | General |
| Category: Oncology | ||||||
| 09/28/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $114.56 | General |
| Category: Rare Disease | ||||||
| 04/24/2018 | US WorldMeds, LLC | Xadago (Drug), APOKYN, MYOBLOC | Food and Beverage | In-kind items and services | $84.31 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 74 | 126 | $20,583 | $6,842 |
| 2021 | 6 | 449 | 740 | $139,917 | $51,703 |
| 2020 | 8 | 587 | 947 | $218,913 | $75,254 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 79 | $11,692 | $4,471 | 38.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,934 | $1,350 | 34.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 13 | 13 | $1,937 | $684.14 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $3,020 | $336.97 | 11.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 140 | 367 | $57,011 | $21,293 | 37.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 74 | 123 | $28,548 | $10,141 | 35.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 88 | 90 | $25,290 | $9,638 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 65 | $9,815 | $4,237 | 43.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 60 | 62 | $9,991 | $3,700 | 37.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 32 | 33 | $9,262 | $2,692 | 29.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 191 | 479 | $80,325 | $27,492 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 102 | 103 | $45,135 | $16,651 | 36.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 83 | 147 | $37,461 | $12,553 | 33.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 123 | 127 | $31,968 | $11,115 | 34.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 26 | 27 | $12,879 | $3,793 | 29.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 25 | 25 | $5,100 | $1,409 | 27.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 23 | 23 | $3,565 | $1,295 | 36.3% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 14 | 16 | $2,480 | $946.25 | 38.2% |
About Dr. Darshan Lal, MD
Dr. Darshan Lal, MD is a Internal Medicine healthcare provider based in Ephrata, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1043617830.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darshan Lal, MD has received a total of $886.72 in payments from pharmaceutical and medical device companies, with $235.25 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Education" ($687.85).
As a Medicare-enrolled provider, Lal has provided services to 1,110 Medicare beneficiaries, totaling 1,813 services with total Medicare billing of $133,799. Data is available for 3 years (2020–2022), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Ephrata, PA
- Active Since 11/24/2014
- Last Updated 06/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043617830
Products in Payments
- ULTOMIRIS (Biological) $114.56
- FOTIVDA (Drug) $89.99
- JEVTANA (Drug) $89.00
- Xadago (Drug) $84.31
- Trodelvy (Drug) $73.99
- SOLIRIS (Biological) $69.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ephrata
Arun Agrawal, Md, MD
Internal Medicine — Payments: $8,661
Agnieszka Mochon, Md, MD
Internal Medicine — Payments: $3,350
Prasad Krishnakurup, M.d, M.D
Internal Medicine — Payments: $1,945
Dr. Michael Delacruz, M.d, M.D
Internal Medicine — Payments: $701.39
Dr. Eugene Camerino, D.o, D.O
Internal Medicine — Payments: $518.77
Andrew Ambort, Do, DO
Internal Medicine — Payments: $272.99